Anıl Aktaş Samur

Biallelic loss of BCMA as a resistance mechanism to CAR T cell therapy in a patient with multiple myeloma

Mehmet Samur, Mariateresa Fulciniti, Anıl Aktaş Samur et al. · Nature Communications · 2021 · 388 citations · Full text

ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma

Matteo Marchesini, Yamini Ogoti, Elena Fiorini et al. · Cancer Cell · 2017 · 158 citations · Full text

Hematological Malignancy, Transcriptional Regulation, Immunology +7

Genome-Wide Somatic Alterations in Multiple Myeloma Reveal a Superior Outcome Group

Mehmet Samur, Anıl Aktaş Samur, Mariateresa Fulciniti et al. · Journal of Clinical Oncology · 2020 · 75 citations · Full text

Deciphering the chronology of copy number alterations in Multiple Myeloma

Anıl Aktaş Samur, Stéphane Minvielle, Masood A. Shammas et al. · Blood Cancer Journal · 2019 · 63 citations · Full text

Long intergenic non-coding RNAs have an independent impact on survival in multiple myeloma

Mehmet Samur, Stéphane Minvielle, Annamaria Gullà et al. · Leukemia · 2018 · 55 citations · Full text

Multiple Myeloma, Intergenic Non-coding Rnas, Independent Impact +9